Trials / Completed
CompletedNCT00543647
Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People
A Double-blind, Cross-over, Placebo-controlled Study Evaluating the Effect of Fenofibrate 160 mg Tablets on Glomerular Filtration Rate and Other Renal Function Test in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to test the effect of fenofibrate treatment on glomerular filtration rate (GFR), kidney hemodynamics and tubular function in middle-aged subjects with normal kidney function to further investigate the increase in creatinine levels observed in fenofibrate-treated subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fenofibrate 160 mg tablet | |
| DRUG | Placebo |
Timeline
- Start date
- 2002-08-01
- Completion
- 2003-03-01
- First posted
- 2007-10-15
- Last updated
- 2015-01-19
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00543647. Inclusion in this directory is not an endorsement.